PML is a protein associated with discrete spherical structures within the nucleus of normal cells. A defect in PML expression is observed in acute promyelocytic leukaemia as a consequence of a chromosomal translocation involving the genes encoding PML and the retinoic acid receptor (RARe). Disruption of PML bodies also occurs during herpes simplex virus infection after the immediate early protein Vmw110 has become associated with PML bodies. In this study, we followed the fate of PML bodies in human fibroblasts during the course of a human cytomegalovirus (CMV) infection.
PML is a protein associated with discrete spherical structures within the nucleus of normal cells. A defect in PML expression is observed in acute promyelocytic leukaemia as a consequence of a chromosomal translocation involving the genes encoding PML and the retinoic acid receptor (RARe). Disruption of PML bodies also occurs during herpes simplex virus infection after the immediate early protein Vmw110 has become associated with PML bodies. In this study, we followed the fate of PML bodies in human fibroblasts during the course of a human cytomegalovirus (CMV) infection.
Disruption of PML bodies was observed to be dependent on de novo CMV gene expression and to occur within 4 h post-infection, concomitant with the onset of CMV IE gene expression. Although a transient increase in the number of PML bodies could be observed in some cells, PML exists predominantly as a diffuse nuclear protein during both the early and late stages of CMV infection. Although the function of PML bodies is still uncertain, their disruption may be important for efficient herpes virus replication.
A novel nuclear body has recently been identified in immunohistochemical studies using autoimmune sera. In normal cells, these nuclear bodies (also referred to as ND10, PODs or Kr bodies) appear as discrete dots (approximately 0.3 gm in diameter) and consist of at least three cellular protein species, including PML and spl00 (Ascoli & Maul 1991; Stuurman et al., 1992) . A defect in PML expression observed in acute promyelocytic leukaemia (APL) produces a condition in which promyelocytes fail to differentiate. A translocation event between chromosomes 16 and 18 results in the generation and expression of three novel gene products: a PML/~ retinoic acid receptor (RARe) fusion protein, a RAR~/PML fusion protein and a truncated form of PML (reviewed Grignani et al., 1993) . This genetic translocation is associated with an abnormal distribution of PML; PML bodies are smaller, more numerous and present in both nucleus and cytosol. However, upon treatment with retinoic acid the structure of the PML bodies becomes normal and this is accompanied by blast differentiation and remission from the disease state (Dyck et al., 1994; Koken et al., 1994) .
Disruption of PML bodies is also observed during herpes simplex type 1 (HSV-1) infection where the effect has been attributed to the action of the immediate early * Author for correspondence. Fax +44 1222 745 003. e-mail WMDGWW@CARDIFF.AC.UK (IE) protein Vmw110 (Maul et al., 1993 ; Maul & Everett, 1994; Everett & Maul, 1994) . HSV-1 Vmwll0 is a wellcharacterized activator of viral gene expression and is required for efficient replication in vitro. CMV has been shown to exhibit a capacity to rescue HSV-1 Vmwll0 deletion mutants, a result which suggests that CMV possesses a gene or genes encoding an analogous function (Stow & Stow, 1989) . Furthermore, Maul et al. (1993) reported that CMV infection also exerted an effect on PML bodies at 24h post-infection (p.i.). Since redistribution of PML may be a general feature of herpesvirus infection, we investigated further the effect of CMV infection on PML bodies.
Human fetal foreskin fibroblasts (HFFF cells) were either mock-infected, infected with CMV (strain AD169) or infected with an equivalent amount of UV-inactivated CMV for a period of 2 h before virus was removed and medium replaced. The inactivated virus stock was given the minimal exposure to UV light required to abolish detectable virus infectivity (reduction in virus titre of > 10 ~) and de novo CMV gene expression as monitored by immunofluorescence against the major IE protein (IEI). Cells were fixed in acetone/methanol (1:1, v/v) at various times p.i. and indirect immunofluorescence performed as described previously (Wilkinson & Akrigg, 1992) . Monoclonal antibodies (MAb) specific for PML (5El0; Stuurman et al., 1992) and CMV IE1 (1D6-6) or CMV-seropositive human sera were used as primary antibody and FITC-conjugated rabbit anti-mouse 0001-3314 © 1995 SGM The effect of CMV on the subcellular localization of PML in H F F F cells was investigated at various times post-infection. PML is associated with a characteristic punctate pattern of distribution in the nucleoplasm (Stuurman et al., 1992) . Human fibroblasts contained an average of 20 discrete PML bodies of unequal size and staining intensity (Fig. 1 a) . Expression of CMV IE1 was used to monitor the proportion of cells infected with virus. Under the conditions used in this experiment, the characteristic nuclear immunofluorescence pattern associated with expression of the major IE protein was not detected after exposure to virus for 2 h but could be clearly observed at 4 h p.i., at which time the majority of cells (55%) stained positive for IE1 (Fig. lb) . A significant alteration in the distribution of PML coincided with the onset of CMV IE gene expression. While a dramatic increase in the number PML bodies was observed in some cells, in others the pattern of PMLassociated immunoftuorescent staining was much more diffuse but still restricted to the nucleus ( Fig. 1 c and jr) . At later time points, the PML micropunctate pattern was observed less frequently and a diffuse pattern of nuclear staining predominated (Fig. 1 g) .
Since the distribution of PML in CMV-infected cells was similar to that of CMV IE1 (Fig. l b, e) , the possibility that the anti-PML MAb 5E10 could be crossreacting with an epitope in IE1 was considered. Since the MAb 5E10 does not recognize an epitope in murine cells, this question was addressed using the murine NIH-3T3 fibroblast cell line. When NIH-3T3 cells were infected with CMV, the IE 1 gene product was recognized by the specific anti-IE1 MAb but not by the MAb to PML (results not shown).
Cells displaying the altered PML-staining pattern were presumed to be infected with CMV as a similar proportion of cells were shown to express the CMV IE antigen (compare Fig. l b and c) . When 100% of cells were infected with CMV, the disintegration of PML bodies was observed in all cells (not shown). Furthermore, in a dual-staining experiment, cells reacted with 5E10 were also reacted with CMV-positive human sera to identify CMV-infected cells. This experiment indicated that the disruption of PML bodies was restricted to CMV-infected cells (Fig. 2) .
The observation that the integrity of PML-associated nuclear bodies was challenged as early as 4 h p.i. suggested that the effect was probably caused either by an IE gene product or a structural component of the infecting virus particle. The latter option was tested in two ways. By exposing CMV stocks to UV light, the capacity of the virus both to replicate and express IE gene products can be inactivated, yet the treated virus remains capable of attaching to and entering cells. The result illustrated in Fig. 1 (d and h) clearly shows that UV-inactivated CMV was unable to affect the distribution of PML bodies. In the second experiment, an inhibitor of protein synthesis (100 gg/ml cycloheximide) was used to block IE gene expression in CMV-infected cells (Fig. 3a and b) . Cycloheximide, by itself, did not (Fig. 3b,f) . Furthermore, treatment of CMV-infected cells with the inhibitor of CMV DNA replication phosphonoacetic acid (PAA) was unable to prevent the disruption of PML bodies (Fig. 3g) . PAA by itself, had no apparent effect on PML distribution in uninfected cells (not shown). Thus, viral DNA replication, with its potential for the generation and disruption of nuclear structures, was not required for this process.
We have demonstrated that a CMV-encoded gene product(s) expressed during the first 4 h p.i. caused the disintegration of PML bodies resulting in the dispersal of PML antigen throughout the nucleus. Although the kinetics of the reaction are consistent with PML disruption being a function of a CMV IE gene product, as is the case with HSV-1, the possibility that a CMV early gene product is responsible has not been eliminated. At least four regions of the CMV genome (UL36-38, UL122-123, TRS1 and US3) are expressed at IE times (Wilkinson et al., 1984; Weston, 1988; Chee et al., 1990 , Stasiak & Mocarski, 1992 and all have been implicated in regulating virus gene expression. Analysis of the CMV genomic sequence has, however, not identified homology between any predicted CMV gene product and HSV-1 Vmw110 (Chee et al., 1990) .
Although the function of the PML bodies remains unknown, it has been proposed that the PML-RAR fusion product which disrupts PML bodies in APL patients acts as a oncoprotein (Dyck et al., 19943 . The genetic defect in APL leads to a block in differentiation and a clonal expansion of promyelocytes. The role of PML in myelocyte differentiation may be relevant to CMV pathogenesis. Although bone marrow progenitors appear to be unable to support CMV gene expression, they can be infected with the virus in vitro and PCR has shown that such cells in seropositive individuals harbour the viral genome (Minton et al., 1994) . Following differentiation along the monocyte/macrophage lineage, CMV gene expression appears to become activated, bone marrow progenitors may therefore represent a potential site of CMV latency. However, the disintegration of PML bodies that we have observed during CMV infection may be a more general property of herpesvirus infections.
